2014-04-02 21:01:04 - Finland Pharmaceuticals and Healthcare Report Q1 2014 - a new market research report on companiesandmarkets.com
The excellent regulatory environment, ageing population, preference for patented medicines and encouraging macroeconomic growth prospects will provide stable revenue-generating opportunities for multinational pharmaceutical companies. However, the pharmaceutical industry will be a target for further cost-containment policies and experience more price erosions and generic competition.
Headline Expenditure Projections:
- Pharmaceuticals: EUR2.92bn (US$3.70bn) in 2012 to EUR2.96bn (US$3.94bn) in 2013;+1.7% in local currency terms and +6.5% in US dollar terms. Forecast upwardly revised in light of the more promising macroeconomic forecast.
- Healthcare: EUR17.00bn (US$21.58bn) in 2012 to EUR17.47bn (US$23.24bn) in 2013; +2.8% in local currency terms and +7.7% in US dollar terms. Forecast broadly unchanged from Q413.
Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.